Home
All Journals
Expert Opinion on Therapeutic Patents
List of Issues
Volume 31, Issue 4

Expert Opinion on Therapeutic Patents

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Therapeutic Patents, Volume 31, Issue 4 (2021)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Patents, Volume 31, Issue 4 (2021)

See all volumes and issues

Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Volume 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Vol 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Coronavirus special issue

Foreword

Article

Coronaviruses

Claudiu T. Supuran

Pages: 291-294

Published online: 30 Mar 2021

First Page PreviewforCoronaviruses | Full Text | References | PDF (285.3 KB) | EPUB

1712 Views
7 CrossRef citations
0Altmetric

Free Access

Review

Repurposing drugs for the management of COVID-19

Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani & Mattia Mori

Pages: 295-307

Published online: 31 Dec 2020

AbstractforRepurposing drugs for the management of COVID-19 | Full Text | References | PDF (1.6 MB) | EPUB

4729 Views
38 CrossRef citations
0Altmetric

Protease inhibitors targeting the main protease and papain-like protease of coronaviruses

Clemente Capasso, Alessio Nocentini & Claudiu T Supuran

Pages: 309-324

Published online: 12 Dec 2020

AbstractforProtease inhibitors targeting the main protease and papain-like protease of coronaviruses | Full Text | References | PDF (5.9 MB) | EPUB

3360 Views
15 CrossRef citations
0Altmetric

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

Ilaria Vicenti, Maurizio Zazzi & Francesco Saladini

Pages: 325-337

Published online: 03 Mar 2021

AbstractforSARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19 | Full Text | References | PDF (1.5 MB) | EPUB

6476 Views
67 CrossRef citations
0Altmetric

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents

Austin N. Spratt, Fabio Gallazzi, Thomas P. Quinn, Christian L. Lorson, Anders Sönnerborg & Kamal Singh

Pages: 339-350

Published online: 21 Apr 2021

AbstractforCoronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents | Full Text | References | PDF (10.1 MB) | EPUB

5163 Views
2 CrossRef citations
0Altmetric

Open Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Anticancer drugs: where are we now?

Giuseppina De Simone et al.

Editorial | Published online: 15 May 2024

Free Access

Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019-June 2023

Esther C. Y. Lee et al.

Review Article | Published online: 14 May 2024

Recent trends and challenges to overcome Pseudomonas aeruginosa infections

Alessandra Ammazzalorso et al.

Review Article | Published online: 3 May 2024

An insight into the last 5-year patents on porphyromonas gingivalis and streptococcus mutans, the pivotal pathogens in the oral cavity

Bianca Laura Bernardoni et al.

Review Article | Published online: 29 Apr 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Patents (Vol.31, Iss.4, 2021)

Coronavirus special issue

Coronavirus special issue

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?